BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Seyedian SS, Nokhostin F, Malamir MD. A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease. J Med Life 2019;12:113-22. [PMID: 31406511 DOI: 10.25122/jml-2018-0075] [Cited by in F6Publishing: 33] [Reference Citation Analysis]
Number Citing Articles
1 Jia Q, Zhang H, Su Y, Liu X, Bai J, Lang W, Shi Q, Feng M. Strictosamide alleviates the inflammation in an acute ulcerative colitis (UC) model. J Physiol Biochem 2021;77:283-94. [PMID: 33595775 DOI: 10.1007/s13105-021-00796-y] [Reference Citation Analysis]
2 Chiu E, Oleynick C, Raman M, Bielawska B. Optimizing Inpatient Nutrition Care of Adult Patients with Inflammatory Bowel Disease in the 21st Century. Nutrients 2021;13:1581. [PMID: 34065070 DOI: 10.3390/nu13051581] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Marinho A, Nunes C, Reis S. Hyaluronic Acid: A Key Ingredient in the Therapy of Inflammation. Biomolecules 2021;11:1518. [PMID: 34680150 DOI: 10.3390/biom11101518] [Reference Citation Analysis]
4 Kim JT, Napier DL, Kim J, Li C, Lee EY, Weiss HL, Wang Q, Evers BM. Ketogenesis alleviates TNFα-induced apoptosis and inflammatory responses in intestinal cells. Free Radic Biol Med 2021;172:90-100. [PMID: 34087430 DOI: 10.1016/j.freeradbiomed.2021.05.032] [Reference Citation Analysis]
5 Reichardt SD, Amouret A, Muzzi C, Vettorazzi S, Tuckermann JP, Lühder F, Reichardt HM. The Role of Glucocorticoids in Inflammatory Diseases. Cells 2021;10:2921. [PMID: 34831143 DOI: 10.3390/cells10112921] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
6 Spatz M, Richard ML. Overview of the Potential Role of Malassezia in Gut Health and Disease. Front Cell Infect Microbiol 2020;10:201. [PMID: 32528901 DOI: 10.3389/fcimb.2020.00201] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
7 Vrdoljak J, Vilović M, Živković PM, Tadin Hadjina I, Rušić D, Bukić J, Borovac JA, Božić J. Mediterranean Diet Adherence and Dietary Attitudes in Patients with Inflammatory Bowel Disease. Nutrients 2020;12:E3429. [PMID: 33171662 DOI: 10.3390/nu12113429] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
8 Veenstra JP, Vemu B, Tocmo R, Nauman MC, Johnson JJ. Pharmacokinetic Analysis of Carnosic Acid and Carnosol in Standardized Rosemary Extract and the Effect on the Disease Activity Index of DSS-Induced Colitis. Nutrients 2021;13:773. [PMID: 33673488 DOI: 10.3390/nu13030773] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
9 Zajączkowska Ż, Akutko K, Kváč M, Sak B, Szydłowicz M, Hendrich AB, Iwańczak B, Kicia M. Enterocytozoon Bieneusi Infects Children With Inflammatory Bowel Disease Undergoing Immunosuppressive Treatment. Front Med (Lausanne) 2021;8:741751. [PMID: 34660646 DOI: 10.3389/fmed.2021.741751] [Reference Citation Analysis]
10 Ghavami SB, Yadegar A, Aghdaei HA, Sorrentino D, Farmani M, Mir AS, Azimirad M, Balaii H, Shahrokh S, Zali MR. Immunomodulation and Generation of Tolerogenic Dendritic Cells by Probiotic Bacteria in Patients with Inflammatory Bowel Disease. Int J Mol Sci 2020;21:E6266. [PMID: 32872480 DOI: 10.3390/ijms21176266] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Jiang F, Fu X, Kuang K, Fan D, Koundal D. Artificial Intelligence Algorithm-Based Differential Diagnosis of Crohn’s Disease and Ulcerative Colitis by CT Image. Computational and Mathematical Methods in Medicine 2022;2022:1-12. [DOI: 10.1155/2022/3871994] [Reference Citation Analysis]
12 Gade AK, Douthit NT, Townsley E. Medical Management of Crohn's Disease. Cureus. 2020;12:e8351. [PMID: 32617224 DOI: 10.7759/cureus.8351] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Bromke MA, Krzystek-Korpacka M. Bile Acid Signaling in Inflammatory Bowel Disease. Int J Mol Sci 2021;22:9096. [PMID: 34445800 DOI: 10.3390/ijms22169096] [Reference Citation Analysis]
14 Marton LT, Goulart RA, Carvalho ACA, Barbalho SM. Omega Fatty Acids and Inflammatory Bowel Diseases: An Overview. Int J Mol Sci 2019;20:E4851. [PMID: 31574900 DOI: 10.3390/ijms20194851] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 8.3] [Reference Citation Analysis]
15 Wanes D, Toutounji M, Sebai H, Rizk S, Naim HY. Rosa canina L. Can Restore Endoplasmic Reticulum Alterations, Protein Trafficking and Membrane Integrity in a Dextran Sulfate Sodium-Induced Inflammatory Bowel Disease Phenotype. Nutrients 2021;13:441. [PMID: 33572926 DOI: 10.3390/nu13020441] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Antunes JC, Seabra CL, Domingues JM, Teixeira MO, Nunes C, Costa-Lima SA, Homem NC, Reis S, Amorim MTP, Felgueiras HP. Drug Targeting of Inflammatory Bowel Diseases by Biomolecules. Nanomaterials (Basel) 2021;11:2035. [PMID: 34443866 DOI: 10.3390/nano11082035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
17 Wang T, Yu R, Zhu L, Wang X, Yang B. Differences in the Intestinal Flora of Patients with Inflammatory Bowel Disease in Southwest China. Indian J Microbiol. [DOI: 10.1007/s12088-022-01014-z] [Reference Citation Analysis]
18 Chandwe K, Kelly P. Colostrum Therapy for Human Gastrointestinal Health and Disease. Nutrients 2021;13:1956. [PMID: 34200282 DOI: 10.3390/nu13061956] [Reference Citation Analysis]
19 Farsi F, Ebrahimi-Daryani N, Barati M, Janani L, Karimi MY, Akbari A, Irandoost P, Mesri Alamdari N, Agah S, Vafa M. Effects of coenzyme Q10 on health-related quality of life, clinical disease activity and blood pressure in patients with mild to moderate ulcerative colitis: a randomized clinical trial. Med J Islam Repub Iran 2021;35:3. [PMID: 33996654 DOI: 10.47176/mjiri.35.3] [Reference Citation Analysis]
20 Hybar H, Saki N, Maleknia M, Moghaddasi M, Bordbar A, Naghavi M. Aspirin exacerbated respiratory disease (AERD): molecular and cellular diagnostic & prognostic approaches. Mol Biol Rep 2021;48:2703-11. [PMID: 33625688 DOI: 10.1007/s11033-021-06240-0] [Reference Citation Analysis]
21 Pascoal LB, Palma BB, Chaim FHM, de Castro MM, Damázio TA, Franceschini APMF, Milanski M, Velloso LA, Leal RF. New translational and experimental insights into the role of pro-resolving lipid mediators in inflammatory bowel disease. World J Exp Med 2022; 12(1): 1-15 [DOI: 10.5493/wjem.v12.i1.1] [Reference Citation Analysis]
22 Qiao D, Zhang Z, Zhang Y, Chen Q, Chen Y, Tang Y, Sun X, Tang Z, Dai Y. Regulation of Endoplasmic Reticulum Stress-Autophagy: A Potential Therapeutic Target for Ulcerative Colitis. Front Pharmacol 2021;12:697360. [PMID: 34588980 DOI: 10.3389/fphar.2021.697360] [Reference Citation Analysis]
23 Hsieh YH, Chung CH, Sun CA, Chen PH, Chen YH, Liang CM, Chen JT, Chien WC, Chen CL. Association between Optic Neuritis and Inflammatory Bowel Disease: A Population-Based Study. J Clin Med 2021;10:688. [PMID: 33578895 DOI: 10.3390/jcm10040688] [Reference Citation Analysis]
24 Xiao Y, Xu B, Bordiga M, Li H, Travaglia F, Bai S, Chen J, Bai W. Cyanidin-3-O-Glucoside Supplement Improves Sperm Quality and Spermatogenesis in a Mice Model of Ulcerative Colitis. Nutrients 2022;14:984. [DOI: 10.3390/nu14050984] [Reference Citation Analysis]
25 Wang Q, Wang C, Abdullah, Tian W, Qiu Z, Song M, Cao Y, Xiao J. Hydroxytyrosol Alleviates Dextran Sulfate Sodium-Induced Colitis by Modulating Inflammatory Responses, Intestinal Barrier, and Microbiome. J Agric Food Chem 2022. [PMID: 35133830 DOI: 10.1021/acs.jafc.1c07568] [Reference Citation Analysis]
26 Tao Z, Zhou X, Zhang Y, Pu W, Yang Y, Wei F, Zhou Q, Zhang L, Du Z, Wu J. Xi Lei San Attenuates Dextran Sulfate Sodium-Induced Colitis in Rats and TNF-α-Stimulated Colitis in CACO2 Cells: Involvement of the NLRP3 Inflammasome and Autophagy. Mediators Inflamm 2021;2021:1610251. [PMID: 33967625 DOI: 10.1155/2021/1610251] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Sriram A, Tangirala S, Atmakuri S, Hoque S, Modani S, Srivastava S, Mahajan S, Maji I, Kumar R, Khatri D, Madan J, Singh PK. Budding Multi-matrix Technology-a Retrospective Approach, Deep Insights, and Future Perspectives. AAPS PharmSciTech 2021;22:264. [PMID: 34734325 DOI: 10.1208/s12249-021-02133-4] [Reference Citation Analysis]
28 Marônek M, Marafini I, Gardlík R, Link R, Troncone E, Monteleone G. Metalloproteinases in Inflammatory Bowel Diseases. J Inflamm Res 2021;14:1029-41. [PMID: 33790618 DOI: 10.2147/JIR.S288280] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
29 Gaspar R, Branco CC, Macedo G. Liver manifestations and complications in inflammatory bowel disease: A review. World J Hepatol 2021; 13(12): 1956-1967 [DOI: 10.4254/wjh.v13.i12.1956] [Reference Citation Analysis]
30 Negi S, Saini S, Tandel N, Sahu K, Mishra RPN, Tyagi RK. Translating Treg Therapy for Inflammatory Bowel Disease in Humanized Mice. Cells 2021;10:1847. [PMID: 34440615 DOI: 10.3390/cells10081847] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Kondubhatla K, Kaushal A, Daoud A, Shabbir H, Mostafa JA. Pro-Atherogenic Inflammatory Mediators in Inflammatory Bowel Disease Patients Increase the Risk of Thrombosis, Coronary Artery Disease, and Myocardial Infarction: A Scientific Dilemma. Cureus 2020;12:e10544. [PMID: 33062549 DOI: 10.7759/cureus.10544] [Reference Citation Analysis]
32 Kim SH, Kwon D, Son SW, Jeong TB, Lee S, Kwak JH, Cho JY, Hwang DY, Seo MS, Kim KS, Jung YS. Inflammatory responses of C57BL/6NKorl mice to dextran sulfate sodium-induced colitis: comparison between three C57BL/6 N sub-strains. Lab Anim Res 2021;37:8. [PMID: 33509279 DOI: 10.1186/s42826-021-00084-2] [Reference Citation Analysis]
33 Monteros MJM, Galdeano CM, Balcells MF, Weill R, De Paula JA, Perdigón G, Cazorla SI. Probiotic lactobacilli as a promising strategy to ameliorate disorders associated with intestinal inflammation induced by a non-steroidal anti-inflammatory drug. Sci Rep 2021;11:571. [PMID: 33436961 DOI: 10.1038/s41598-020-80482-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
34 Lajczak-McGinley NK, Porru E, Fallon CM, Smyth J, Curley C, McCarron PA, Tambuwala MM, Roda A, Keely SJ. The secondary bile acids, ursodeoxycholic acid and lithocholic acid, protect against intestinal inflammation by inhibition of epithelial apoptosis. Physiol Rep 2020;8:e14456. [PMID: 32562381 DOI: 10.14814/phy2.14456] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
35 Luzentales-Simpson M, Pang YCF, Zhang A, Sousa JA, Sly LM. Vedolizumab: Potential Mechanisms of Action for Reducing Pathological Inflammation in Inflammatory Bowel Diseases. Front Cell Dev Biol 2021;9:612830. [PMID: 33614645 DOI: 10.3389/fcell.2021.612830] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Story L, Rafique S, Samadi N, Mawdsley J, Singh B, Banerjee A. Lower gastrointestinal bleeding in pregnancy: Differential diagnosis, assessment and management. Obstet Med 2021;14:129-34. [PMID: 34646340 DOI: 10.1177/1753495X20948300] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
37 Damoogh S, Vosough M, Hadifar S, Rasoli M, Gorjipour A, Falsafi S, Behrouzi A. Evaluation of E. coli Nissle1917 derived metabolites in modulating key mediator genes of the TLR signaling pathway. BMC Res Notes 2021;14:156. [PMID: 33902702 DOI: 10.1186/s13104-021-05568-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Okobi OE, Udoete IO, Fasehun OO, Okobi T, Evbayekha EO, Ekabua JJ, Elukeme H, Ebong IL, Ajayi OO, Olateju IV, Taiwo A, Anaya IC, Omole JA, Nkongho MB, Ojinnaka U, Ajibowo AO, Ogbeifun OE, Ugbo OO, Okorare O, Akinsola Z, Olusoji RA, Amanze IO, Nwafor JN, Ukoha NA, Elimihele TA. A Review of Four Practice Guidelines of Inflammatory Bowel Disease. Cureus 2021;13:e16859. [PMID: 34513436 DOI: 10.7759/cureus.16859] [Reference Citation Analysis]
39 Wang S, Zhang S, Huang S, Wu Z, Pang J, Wu Y, Wang J, Han D. Resistant Maltodextrin Alleviates Dextran Sulfate Sodium-Induced Intestinal Inflammatory Injury by Increasing Butyric Acid to Inhibit Proinflammatory Cytokine Levels. Biomed Res Int 2020;2020:7694734. [PMID: 33015180 DOI: 10.1155/2020/7694734] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
40 Velazquez FN, Hernandez-Corbacho M, Trayssac M, Stith JL, Bonica J, Jean B, Pulkoski-Gross MJ, Carroll BL, Salama MF, Hannun YA, Snider AJ. Bioactive sphingolipids: Advancements and contributions from the laboratory of Dr. Lina M. Obeid. Cell Signal 2021;79:109875. [PMID: 33290840 DOI: 10.1016/j.cellsig.2020.109875] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
41 Singh A, Kaur K, Mandal UK, Narang RK. Nanoparticles as Budding Trends in Colon Drug Delivery for the Management of Ulcerative Colitis. CNANOM 2020;10:225-47. [DOI: 10.2174/2468187310999200621200615] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
42 El-atawneh S, Goldblum A. Candidate Therapeutics by Screening for Multitargeting Ligands: Combining the CB2 Receptor With CB1, PPARγ and 5-HT4 Receptors. Front Pharmacol 2022;13:812745. [DOI: 10.3389/fphar.2022.812745] [Reference Citation Analysis]
43 O'Carroll SJ, Cook WH, Young D. AAV Targeting of Glial Cell Types in the Central and Peripheral Nervous System and Relevance to Human Gene Therapy. Front Mol Neurosci 2020;13:618020. [PMID: 33505247 DOI: 10.3389/fnmol.2020.618020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
44 Giraud EL, Thomas PWA, van Lint JA, van Puijenbroek EP, Römkens TEH, West RL, Russel MGVM, Jansen JM, Jessurun NT, Hoentjen F; IBDREAM registry. Adverse Drug Reactions from Real-World Data in Inflammatory Bowel Disease Patients in the IBDREAM Registry. Drug Saf 2021;44:581-8. [PMID: 33538994 DOI: 10.1007/s40264-021-01045-3] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
45 Kikut J, Drozd A, Mokrzycka M, Grzybowska-chlebowczyk U, Ziętek M, Szczuko M. There Is a Differential Pattern in the Fatty Acid Profile in Children with CD Compared to Children with UC. JCM 2022;11:2365. [DOI: 10.3390/jcm11092365] [Reference Citation Analysis]
46 Zergham AS, Sekhon AK, Mebasher A, Tserenpil G, Malik BH. Inflammatory Bowel Disease and Obstructive Pulmonary Disease: A Two-way Association? Cureus 2020;12:e6836. [PMID: 32181078 DOI: 10.7759/cureus.6836] [Reference Citation Analysis]
47 Ward MC, Studer B, Nora I, Seepaulsing N, Loewe C. Primary Sclerosing Cholangitis in Crohn's Disease: An Atypical Complication. Cureus 2021;13:e14964. [PMID: 34123661 DOI: 10.7759/cureus.14964] [Reference Citation Analysis]
48 Lin TY, Lai YF, Chen PH, Chung CH, Chen CL, Chen YH, Chen JT, Kuo PC, Chien WC, Hsieh YH. Association Between Ischemic Optic Neuropathy and Inflammatory Bowel Disease: A Population-Based Cohort Study in Taiwan. Front Med (Lausanne) 2021;8:753367. [PMID: 34651004 DOI: 10.3389/fmed.2021.753367] [Reference Citation Analysis]
49 Kim YS, Zhang H, Lee S, Park S, Noh M, Kim YM, Kwon YG. CU06-1004 Alleviates Experimental Colitis by Modulating Colonic Vessel Dysfunction. Front Pharmacol 2020;11:571266. [PMID: 33041812 DOI: 10.3389/fphar.2020.571266] [Reference Citation Analysis]
50 Ghanawat M, Arjmand B, Rahim F. The Pro-tumor and Anti-tumor Effects of NLRP3 Inflammasome as a New Therapeutic Option for Colon Cancer: a Meta-analysis of Pre-clinical Studies. J Gastrointest Cancer 2022. [PMID: 35072914 DOI: 10.1007/s12029-022-00805-3] [Reference Citation Analysis]